doi.org/10.1001/jamainternmed.2021.4607

Other

Approval of Aducanumab for Alzheimer Disease—The FDA’s Perspective

,

,

JAMA Internal Medicine23.30

Volume: 181, Issue: 10, Pages: 1276 - 1276

Published: Jul 13, 2021

Paper Fields

Paper Details

Title

Approval of Aducanumab for Alzheimer Disease—The FDA’s Perspective

DOI

doi.org/10.1001/jamainternmed.2021.4607

Published Date

Jul 13, 2021

Journal

JAMA Internal Medicine

Volume

181

Issue

10

Pages

1276 - 1276

Notes

History